{
    "Trade/Device Name(s)": [
        "i-STAT TBI Cartridge with the i-STAT Alinity System"
    ],
    "Submitter Information": "Abbott Point of Care Inc.",
    "510(k) Number": "K234143",
    "Predicate Device Reference 510(k) Number(s)": [
        "K201778"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QAT"
    ],
    "Summary Letter Date": "March 27, 2024",
    "Summary Letter Received Date": "December 29, 2023",
    "Submission Date": "December 28, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.5830"
    ],
    "Regulation Name(s)": [
        "Brain Trauma Assessment Test"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Glial fibrillary acidic protein (GFAP)",
        "Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "i-STAT Alinity"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay",
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Multiplex immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "System",
        "Analyzer",
        "Instrument",
        "Accessory",
        "Control",
        "Calibration verification material"
    ],
    "Document Summary": "FDA 510(k) summary for the i-STAT TBI Cartridge with the i-STAT Alinity System, an in vitro diagnostic multiplex immunoassay for GFAP and UCH-L1 in whole blood to aid evaluation of suspected mild traumatic brain injury.",
    "Indications for Use Summary": "A panel of in vitro diagnostic immunoassays for quantitative measurement of GFAP and UCH-L1 in venous whole blood, using the i-STAT Alinity instrument, to assist in determining need for head CT scan in patients (18+ years) with suspected mild traumatic brain injury within 24 hours of injury.",
    "fda_folder": "Immunology"
}